Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic oncology 2022-01, Vol.17 (1), p.10-12
Hauptverfasser: Yamamoto, Hiromasa, Togashi, Yosuke
Format: Artikel
Sprache:eng
Schlagworte:
B7-H1 Antigen
Chemotherapy, Adjuvant
Humans
Lung
Lung Neoplasms - drug therapy
Tumor Microenvironment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 10
container_title Journal of thoracic oncology
container_volume 17
creator Yamamoto, Hiromasa
Togashi, Yosuke
description
doi_str_mv 10.1016/j.jtho.2021.10.019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2612383542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S155608642103313X</els_id><sourcerecordid>2612383542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-eead917db6bdc9b3059b438708386b0a865db5dbae424e1b991672040c9540ef3</originalsourceid><addsrcrecordid>eNp9kM1KAzEUhYMo_lRfwIXM0s3Um0kmnQE3Un-hahFdh0xy62TozNQkFdz5Dr6hT2JKq0vhwr0czjlwP0KOKQwpUHHWDJtQ98MMMhqFIdByi-zTPBcpZQVsb24oBN8jB943ADwHXuySPcZLBgL4Prmfuv7VqbZFk1yiCnU6sa-qMwn9_vx6srpOpg5bDMoHFaxOHqKEie2SC9Ms31UXknGNbR9qdGrxcUh2Zmru8WizB-Tl-up5fJtOHm_uxheTVHM6CimiMiUdmUpURpcVg7ysOCtGULBCVKAKkZsqjkKecaRVWVIxyoCDLnMOOGMDcrruXbj-bYk-yNZ6jfO56rBfepkJmrGC5TyL1mxt1a733uFMLpxtlfuQFOQKo2zkCqNcYVxpEWMMnWz6l1Uk8xf55RYN52sDxi_fLTrptcVOo7EOdZCmt__1_wBE34Py</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612383542</pqid></control><display><type>article</type><title>Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yamamoto, Hiromasa ; Togashi, Yosuke</creator><creatorcontrib>Yamamoto, Hiromasa ; Togashi, Yosuke</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/j.jtho.2021.10.019</identifier><identifier>PMID: 34930604</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>B7-H1 Antigen ; Chemotherapy, Adjuvant ; Humans ; Lung ; Lung Neoplasms - drug therapy ; Tumor Microenvironment</subject><ispartof>Journal of thoracic oncology, 2022-01, Vol.17 (1), p.10-12</ispartof><rights>2021 International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c417t-eead917db6bdc9b3059b438708386b0a865db5dbae424e1b991672040c9540ef3</cites><orcidid>0000-0001-9910-0164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34930604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Togashi, Yosuke</creatorcontrib><title>Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><subject>B7-H1 Antigen</subject><subject>Chemotherapy, Adjuvant</subject><subject>Humans</subject><subject>Lung</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Tumor Microenvironment</subject><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1KAzEUhYMo_lRfwIXM0s3Um0kmnQE3Un-hahFdh0xy62TozNQkFdz5Dr6hT2JKq0vhwr0czjlwP0KOKQwpUHHWDJtQ98MMMhqFIdByi-zTPBcpZQVsb24oBN8jB943ADwHXuySPcZLBgL4Prmfuv7VqbZFk1yiCnU6sa-qMwn9_vx6srpOpg5bDMoHFaxOHqKEie2SC9Ms31UXknGNbR9qdGrxcUh2Zmru8WizB-Tl-up5fJtOHm_uxheTVHM6CimiMiUdmUpURpcVg7ysOCtGULBCVKAKkZsqjkKecaRVWVIxyoCDLnMOOGMDcrruXbj-bYk-yNZ6jfO56rBfepkJmrGC5TyL1mxt1a733uFMLpxtlfuQFOQKo2zkCqNcYVxpEWMMnWz6l1Uk8xf55RYN52sDxi_fLTrptcVOo7EOdZCmt__1_wBE34Py</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Yamamoto, Hiromasa</creator><creator>Togashi, Yosuke</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9910-0164</orcidid></search><sort><creationdate>202201</creationdate><title>Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy</title><author>Yamamoto, Hiromasa ; Togashi, Yosuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-eead917db6bdc9b3059b438708386b0a865db5dbae424e1b991672040c9540ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>B7-H1 Antigen</topic><topic>Chemotherapy, Adjuvant</topic><topic>Humans</topic><topic>Lung</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Togashi, Yosuke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Hiromasa</au><au>Togashi, Yosuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2022-01</date><risdate>2022</risdate><volume>17</volume><issue>1</issue><spage>10</spage><epage>12</epage><pages>10-12</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34930604</pmid><doi>10.1016/j.jtho.2021.10.019</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-9910-0164</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2022-01, Vol.17 (1), p.10-12
issn 1556-0864
1556-1380
language eng
recordid cdi_proquest_miscellaneous_2612383542
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects B7-H1 Antigen
Chemotherapy, Adjuvant
Humans
Lung
Lung Neoplasms - drug therapy
Tumor Microenvironment
title Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A09%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Programmed%20Death-Ligand%201%E2%80%93Rich%20Premetastatic%20Niche%20in%20Adjuvant%20Chemotherapy&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Yamamoto,%20Hiromasa&rft.date=2022-01&rft.volume=17&rft.issue=1&rft.spage=10&rft.epage=12&rft.pages=10-12&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/j.jtho.2021.10.019&rft_dat=%3Cproquest_cross%3E2612383542%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2612383542&rft_id=info:pmid/34930604&rft_els_id=S155608642103313X&rfr_iscdi=true